Sai Life Sciences and the New API Manufacturing Facility: All You Need to Know
Sai Life Sciences and the New API Manufacturing Facility: All You Need to Know Developed and tested to deal with highly active compounds at a containment level of less than 1 g/m3 The first batch of products intended for sale has been put into production. INTRODUCTION Sai Life Sciences, one of India’s most rapidly expanding Contract Research, Development, and Manufacturing Organizations (CRO-CDMO), has just announced the opening of a new High-Potency API (HPAPI) manufacturing facility at its cGMP API Manufacturing campus in Bidar, India. This facility will be located on the Sai Life Sciences campus. With the addition of this new facility, the firm’s experience in HPAPI development and manufacture has been expanded. As a result, the company is now able to provide its clients with a more simplified route for NCE development. In making the announcement, Sai Life Sciences’ Chief Executive Officer and Managing Director Krishna Kanumuri stated, “In recent years, there has been a rise in the ...